Bill > HB41

This bill amends Montana's drug scheduling law to add gabapentin to Schedule V controlled substances, which is a category of drugs with lower potential for abuse. Currently, Schedule V includes certain narcotic drugs with limited quantities of non-narcotic ingredients, stimulants, depressants, anticonvulsant substances, and antimigraine medications. Specifically, the bill inserts gabapentin (chemically known as 1-(aminomethyl)cyclohexaneacetic acid) into the list of depressant substances in Section 50-32-232. Gabapentin is a medication commonly used to treat epilepsy, nerve pain, and other neurological conditions. By adding it to Schedule V, the state is implementing additional regulatory controls over the drug, which likely aims to monitor and potentially restrict its distribution and use due to concerns about misuse or potential adverse effects. The bill appears to be proposed by the Department of Justice and represents a technical update to the existing controlled substances classification system.

Justice

https://bills.legmt.gov/#/laws/bill/20251/LC0174